Published in J Infect Dis on October 09, 2000
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes. Infect Immun (2002) 1.53
Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 1.41
C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect Immun (2001) 1.37
Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin Diagn Lab Immunol (2004) 1.22
Microbial antigenic variation mediated by homologous DNA recombination. FEMS Microbiol Rev (2012) 1.18
Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. Clin Diagn Lab Immunol (2004) 1.12
C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden. Eur J Clin Microbiol Infect Dis (2007) 1.06
Genetic variation at the vlsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle. J Bacteriol (2003) 1.06
Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol (2003) 1.02
C6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis. J Clin Microbiol (2003) 0.99
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99
Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. Clin Vaccine Immunol (2008) 0.89
Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis (2004) 0.89
BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease. Clin Vaccine Immunol (2009) 0.86
Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test. Clin Vaccine Immunol (2006) 0.84
A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin Vaccine Immunol (2006) 0.83
Borrelia burgdorferi sensu lato species in Europe induce diverse immune responses against C6 peptides in infected mice. Clin Vaccine Immunol (2009) 0.83
Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease. Clin Vaccine Immunol (2006) 0.83
Serological detection of Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato and Ehrlichia canis antibodies and Dirofilaria immitis antigen in a countrywide survey in dogs in Poland. Parasitol Res (2014) 0.81
Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine. J Clin Microbiol (2002) 0.79
Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis. Parasitol Res (2015) 0.78
Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy. Int J Gen Med (2016) 0.77
C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis. PLoS One (2015) 0.75
Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease. Sci Rep (2016) 0.75
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41
Co-feeding ticks: Epidemiological significance for tick-borne pathogen transmission. Parasitol Today (1996) 2.67
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect (2004) 2.59
Lyme borreliosis in Europe and North America. Parasitology (2004) 2.37
Chronic lyme disease in the rhesus monkey. Lab Invest (1995) 2.30
Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect Immun (1997) 2.19
Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol (2000) 2.11
An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol (1999) 2.09
Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect Immun (1998) 1.96
Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol Lett (1993) 1.84
Influence of saturation deficit and temperature on Ixodes ricinus tick questing activity in a Lyme borreliosis-endemic area (Switzerland). Parasitol Res (2000) 1.79
Plasmid analysis and restriction fragment length polymorphisms of chromosomal DNA allow a distinction between Borrelia burgdorferi strains. Zentralbl Bakteriol (1990) 1.77
An avian reservoir (Turdus merula) of the Lyme borreliosis spirochetes. Zentralbl Bakteriol (1998) 1.74
PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol (2000) 1.68
Coexistence of Ehrlichia phagocytophila and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Italy as determined by 16S rRNA gene sequencing. J Clin Microbiol (1997) 1.63
Serological follow-up of patients involved in a localized outbreak of leptospirosis. J Clin Microbiol (1991) 1.59
Transmission of Borrelia afzelii from Apodemus mice and Clethrionomys voles to Ixodes ricinus ticks: differential transmission pattern and overwintering maintenance. Parasitology (1999) 1.58
Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun (1994) 1.55
Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect Immun (1999) 1.53
European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr (1996) 1.51
Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun (1999) 1.50
Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci U S A (1997) 1.50
Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 1.41
Abnormal epidermal changes after argon laser treatment. J Am Acad Dermatol (1991) 1.40
Lyme disease. A general survey. Int J Dermatol (1990) 1.39
C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect Immun (2001) 1.37
Strain variation of Lyme disease spirochetes isolated from Ixodes ricinus ticks and rodents collected in two endemic areas in Switzerland. J Med Entomol (1995) 1.37
Epidemiological trend of human leptospirosis in Italy between 1994 and 1996. Eur J Epidemiol (2000) 1.34
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Relationship of Borrelia burgdorferi to its arthropod vectors. Scand J Infect Dis Suppl (1991) 1.32
Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector. Infect Immun (2001) 1.32
Genetic diversity of Borrelia burgdorferi sensu lato isolates obtained from Ixodes ricinus ticks collected in Slovakia. Eur J Epidemiol (1999) 1.30
Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect Immun (1998) 1.29
Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol (1999) 1.28
Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR. J Clin Microbiol (1996) 1.27
The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis (1991) 1.26
Coinoculation of Borrelia spp. with tick salivary gland lysate enhances spirochete load in mice and is tick species-specific. J Parasitol (2002) 1.19
Studies on the interaction between macrophages and leptospires. J Gen Microbiol (1981) 1.19
Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland. J Clin Microbiol (2002) 1.17
Importance of sample preparation for molecular diagnosis of lyme borreliosis from urine. J Clin Microbiol (2002) 1.16
Effects of cartap on isolated mouse phrenic nerve diaphragm and its related mechanism. Toxicol Sci (2000) 1.15
Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field. J Clin Microbiol (2001) 1.15
Expression of outer surface proteins A and C of Borrelia afzelii in Ixodes ricinus ticks and in the skin of mice. Zentralbl Bakteriol (1998) 1.14
Relationship between Borrelia burgdorferi sensu lato species, red squirrels (Sciurus vulgaris) and Ixodes ricinus in enzootic areas in Switzerland. Acta Trop (1998) 1.12
Identification of Borrelia burgdorferi sensu lato species in Europe. Zentralbl Bakteriol (1998) 1.12
CD19(+) cells produce IFN-gamma in mice infected with Borrelia burgdorferi. Eur J Immunol (2001) 1.11
Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother (1995) 1.10
Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anticomplement proteins. Insect Mol Biol (2007) 1.10
Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species. Infect Immun (2000) 1.09
Characterization of Borrelia burgdorferi isolated from different organs of Ixodes ricinus ticks collected in nature. Zentralbl Bakteriol (1994) 1.09
Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun (2000) 1.09
Borrelia burgdorferi in a focus of Lyme borreliosis: epizootiologic contribution of small mammals. Folia Parasitol (Praha) (1993) 1.07
Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis (1998) 1.07
Oligonucleotides specific for pathogenic and saprophytic leptospira occurring in water. FEMS Microbiol Lett (1997) 1.05
Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol (1997) 1.05
A portuguese isolate of Borrelia lusitaniae induces disease in C3H/HeN mice. J Med Microbiol (2001) 1.05
Ixodes ricinus immatures on birds in a focus of Lyme borreliosis. Folia Parasitol (Praha) (1993) 1.05
Ixodes (Pholeoixodes) hexagonus, an efficient vector of Borrelia burgdorferi in the laboratory. Med Vet Entomol (1991) 1.05
Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol (2001) 1.04
Borrelia burgdorferi in rodents (Apodemus flavicollis and A. sylvaticus): duration and enhancement of infectivity for Ixodes ricinus ticks. Eur J Epidemiol (1994) 1.04
Widespread distribution and high prevalence of an alpha-proteobacterial symbiont in the tick Ixodes ricinus. Environ Microbiol (2006) 1.02
Sensitivity of Borrelia and Leptospira to Quinupristin-dalfopristin (Synercid) in vitro. New Microbiol (2001) 1.02
C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi. Infect Immun (2001) 1.02
Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J Bacteriol (2000) 1.02
Survey on the prevalence of leptospira infections in the Italian population. Eur J Epidemiol (1994) 1.01
Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement. Infect Immun (1999) 1.01
Changes in the protein profile and antigenicity of different Borrelia burgdorferi strains after reintroduction to Ixodes ricinus ticks. Parasite Immunol (1992) 1.01
Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J Med Microbiol (1997) 1.01
Real-time homogeneous assay of rapid cycle polymerase chain reaction product for identification of Leptonema illini. Anal Biochem (1998) 1.01
Leptospira icterohemorrhagiae and leptospire peptidolgycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes. Infect Immun (1995) 1.00
DNA relatedness among strains of Leptospira biflexa. Int J Syst Bacteriol (1990) 1.00
Heterogeneity of lipopolysaccharide banding patterns in Leptospira spp. J Gen Microbiol (1986) 1.00
Rapid flow cytometric studies of Borrelia burgdorferi phagocytosis by human polymorphonuclear leukocytes. J Appl Bacteriol (1989) 1.00
Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle. Infect Immun (1997) 0.99
Tick factors and in vitro cultivation influence the protein profile, antigenicity and pathogenicity of a cloned Borrelia garinii isolate from Ixodes ricinus hemolymph. Infection (1996) 0.99
The wild hidden face of Lyme borreliosis in Europe. Microbes Infect (2000) 0.99
Elastase is the only human neutrophil granule protein that alone is responsible for in vitro killing of Borrelia burgdorferi. Infect Immun (1998) 0.98
Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS (2004) 0.98
Expression of Mina53 and its significance in gastric carcinoma. Int J Biol Markers (2008) 0.96
European Lyme borreliosis. Ann N Y Acad Sci (1988) 0.96
Assessment of intraspecific mtDNA variability of European Ixodes ricinus sensu stricto (Acari: Ixodidae). Infect Genet Evol (2007) 0.96
Apodemus sp. rodents, reservoir hosts for Borrelia afzelii in an endemic area in Switzerland. Zentralbl Bakteriol (1997) 0.96
Infection of Ixodes ricinus (Acari: Ixodidae) by Borrelia burgdorferi sensu lato in North Africa. J Med Entomol (1999) 0.95
Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi. Infect Immun (2000) 0.95
The role of antibodies and serum complement in the interaction between macrophages and leptospires. J Gen Microbiol (1982) 0.95
Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo. APMIS (2001) 0.95
Serosurvey on the presence of leptospiral agglutinins in humans in Northern Italy. Eur J Epidemiol (1986) 0.94
Evidence of Dbps (decorin binding proteins) among European strains of Borrelia burgdorferi sensu lato and in the immune response of LB patient sera. FEMS Microbiol Lett (2000) 0.94
Incompatibility of R plasmids from clinical material. Zentralbl Bakteriol Orig A (1979) 0.93
CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand (2011) 0.93
Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol (2001) 0.93
IgE myeloma. Report of a new case and review of the literature. Haematologica (1981) 0.92
Infection of field-collected Ixodes ricinus (Acari: Ixodidae) larvae with Borrelia burgdorferi in Switzerland. J Med Entomol (1994) 0.92
Imported babesiosis diagnosed as malaria. Lancet (1993) 0.92
Is localised scleroderma a Borrelia infection? Lancet (1985) 0.92
Activation of complement by leptospires and its bactericidal activity. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.91
DNA dot-blot hybridization implicates human papillomavirus type 11-DNA in epithelioma cuniculatum. J Med Virol (1989) 0.91